268 related articles for article (PubMed ID: 17416862)
1. PancPRO: risk assessment for individuals with a family history of pancreatic cancer.
Wang W; Chen S; Brune KA; Hruban RH; Parmigiani G; Klein AP
J Clin Oncol; 2007 Apr; 25(11):1417-22. PubMed ID: 17416862
[TBL] [Abstract][Full Text] [Related]
2. "PancPro" as a tool for selecting families eligible for pancreatic cancer screening: an Italian study of incident cases.
Leonardi G; Marchi S; Falconi M; Zerbi A; Ussia V; de Bortoli N; Mosca F; Presciuttini S; Del Chiaro M
Dig Liver Dis; 2012 Jul; 44(7):585-8. PubMed ID: 22281375
[TBL] [Abstract][Full Text] [Related]
3. A risk prediction tool for individuals with a family history of breast, ovarian, or pancreatic cancer: BRCAPANCPRO.
Blackford AL; Childs EJ; Porter N; Petersen GM; Rabe KG; Gallinger S; Borgida A; Syngal S; Cote ML; Schwartz AG; Goggins MG; Hruban RH; Parmigiani G; Klein AP
Br J Cancer; 2021 Dec; 125(12):1712-1717. PubMed ID: 34703010
[TBL] [Abstract][Full Text] [Related]
4. Familial pancreatic cancer: who should be considered for genetic testing?
Kartal K; Guan Z; Tang R; Griffin M; Wang Y; Braun D; Klein AP; Hughes KS
Ir J Med Sci; 2022 Apr; 191(2):641-650. PubMed ID: 33733397
[TBL] [Abstract][Full Text] [Related]
5. BRCAPRO 6.0 Model Validation in Male Patients Presenting for BRCA Testing.
Mitri ZI; Jackson M; Garby C; Song J; Giordano SH; Hortobágyi GN; Singletary CN; Hashmi SS; Arun BK; Litton JK
Oncologist; 2015 Jun; 20(6):593-7. PubMed ID: 25948675
[TBL] [Abstract][Full Text] [Related]
6. Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program.
Dwarte T; McKay S; Johns A; Tucker K; Spigelman AD; Williams D; Stoita A
Hered Cancer Clin Pract; 2019; 17():30. PubMed ID: 31666883
[TBL] [Abstract][Full Text] [Related]
7. Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO.
Biswas S; Tankhiwale N; Blackford A; Barrera AM; Ready K; Lu K; Amos CI; Parmigiani G; Arun B
Breast Cancer Res Treat; 2012 May; 133(1):347-55. PubMed ID: 22270937
[TBL] [Abstract][Full Text] [Related]
8. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
[TBL] [Abstract][Full Text] [Related]
9. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
10. Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer.
Sheel ARG; Harrison S; Sarantitis I; Nicholson JA; Hanna T; Grocock C; Raraty M; Ramesh J; Farooq A; Costello E; Jackson R; Chapman M; Smith A; Carter R; Mckay C; Hamady Z; Aithal GP; Mountford R; Ghaneh P; Hammel P; Lerch MM; Halloran C; Pereira SP; Greenhalf W
Am J Gastroenterol; 2019 Jan; 114(1):155-164. PubMed ID: 30353057
[TBL] [Abstract][Full Text] [Related]
11. Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group.
Capurso G; Paiella S; Carrara S; Butturini G; Secchettin E; Frulloni L; Zerbi A; Falconi M
Dig Liver Dis; 2020 Oct; 52(10):1126-1130. PubMed ID: 32819857
[TBL] [Abstract][Full Text] [Related]
12. Assessment of "gene-environment" interaction in cases of familial and sporadic pancreatic cancer.
Yeo TP; Hruban RH; Brody J; Brune K; Fitzgerald S; Yeo CJ
J Gastrointest Surg; 2009 Aug; 13(8):1487-94. PubMed ID: 19459017
[TBL] [Abstract][Full Text] [Related]
13. International registries of families at high risk of pancreatic cancer.
Greenhalf W; Malats N; Nilsson M; Bartsch D; Neoptolemos J
Pancreatology; 2008; 8(6):558-65. PubMed ID: 18818508
[TBL] [Abstract][Full Text] [Related]
14. Familial pancreatic cancer.
Klein AP; Hruban RH; Brune KA; Petersen GM; Goggins M
Cancer J; 2001; 7(4):266-73. PubMed ID: 11561603
[TBL] [Abstract][Full Text] [Related]
15. Elevated cancer mortality in the relatives of patients with pancreatic cancer.
Wang L; Brune KA; Visvanathan K; Laheru D; Herman J; Wolfgang C; Schulick R; Cameron JL; Goggins M; Hruban RH; Klein AP
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2829-34. PubMed ID: 19843679
[TBL] [Abstract][Full Text] [Related]
16. Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance.
Abe T; Blackford AL; Tamura K; Ford M; McCormick P; Chuidian M; Almario JA; Borges M; Lennon AM; Shin EJ; Klein AP; Hruban RH; Canto MI; Goggins M
J Clin Oncol; 2019 May; 37(13):1070-1080. PubMed ID: 30883245
[TBL] [Abstract][Full Text] [Related]
17. A New Comprehensive Colorectal Cancer Risk Prediction Model Incorporating Family History, Personal Characteristics, and Environmental Factors.
Zheng Y; Hua X; Win AK; MacInnis RJ; Gallinger S; Marchand LL; Lindor NM; Baron JA; Hopper JL; Dowty JG; Antoniou AC; Zheng J; Jenkins MA; Newcomb PA
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):549-557. PubMed ID: 31932410
[TBL] [Abstract][Full Text] [Related]
18. Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.
Stoffel EM; McKernin SE; Brand R; Canto M; Goggins M; Moravek C; Nagarajan A; Petersen GM; Simeone DM; Yurgelun M; Khorana AA
J Clin Oncol; 2019 Jan; 37(2):153-164. PubMed ID: 30457921
[TBL] [Abstract][Full Text] [Related]
19. Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population.
Kim J; Yuan C; Babic A; Bao Y; Clish CB; Pollak MN; Amundadottir LT; Klein AP; Stolzenberg-Solomon RZ; Pandharipande PV; Brais LK; Welch MW; Ng K; Giovannucci EL; Sesso HD; Manson JE; Stampfer MJ; Fuchs CS; Wolpin BM; Kraft P
Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):999-1008. PubMed ID: 32321713
[TBL] [Abstract][Full Text] [Related]
20. Absence of germline BRCA1 mutations in familial pancreatic cancer patients.
Axilbund JE; Argani P; Kamiyama M; Palmisano E; Raben M; Borges M; Brune KA; Goggins M; Hruban RH; Klein AP
Cancer Biol Ther; 2009 Jan; 8(2):131-5. PubMed ID: 19029836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
